Improvement in noninvasive tests ( lsm, fib-4, and apri) is seen through 96 weeks of bulevirtide monotherapy in chd regardless of virologic responseLaurent Castera,Soo Aleman,Pietro Lampertico,Pavel Bogomolov,Dmitry Manuilov,Qi An, Ben L. Da,John F. Flaherty,Renee-Claude Mercier,Audrey H. Lau, Grace Chee, Tatyana Stepanova,Stefan Zeuzem, Heiner Wedemeyer,Marc Bourliere,Fabien Zoulim,Tarik Asselah,Maurizia R. BrunettoHEPATOLOGY(2023)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要